| 18F-Fluorodeoxy
glucose (FDG) uptake in nontraumatic bilateral adrenal hemorrhage secondary
to heparin-associated thrombocytopenia syndrome (HATS)—a case report.
Usha A. Joseph, Bruce J. Barron, and David Q. Wan. Clinical Imaging,
Volume 31, Issue 2, March-April 2007, Pages 137-140. Abstract
| Full
Text and Links |
| Y. M. Kong, D. J. McCormick,
Q. Wan, R. W. Motte, A. A. Giraldo, B. E. Fuller, and C. S. David: Primary
hormonogenic sites as conserved autoepitopes in murine autoimmune thyroiditis:
Second role of iodination. The Journal of Immunology, 1995, 155: 5847-5854. |
| M. Nakashima, Y. M.
Kong, Q. Wan, T. F. Davies: Prospective study of T cell receptor utilization
following the induction of murine thyroiditis. Experimental and Clinical
Endocrinology & Diabetes, 1996, 104, suppl. 4: 46-51. |
| Q. Wan, R. W. Motte,
B. E. Fuller, A. A. Giraldo, D. J. McCormick, C. S. David and Y. M. Kong:
Primary hormonogenic sites as conserved autoepitopes in murine autoimmune
thyroiditis: Role of MHC Class II. Clinical Immunology and Immunopathology.
85(2), 187-194, 1997. |
| Q. Wan, D. J. McCormick,
C. S. David and Y. M. Kong: Thyroglobulin peptides of specific primary hormonogenic
sites can generate cytotoxic T cells and serve as target autoantigens in
experimental autoimmune thyroiditis. Clinical Immunology and Immunopathology.
86(1), 110-114, 1998. 50, 22-30, 1999. |
| Q. Wan, R. Shah, D.
J. McCormick, L. C. Lomo, A. A. Giraldo, C. S. David and Y. M. Kong: H2E
transgenic class II-negative mice can distinguish self from non-self in
susceptibility to heterologous thyroglobulins in autoimmune thyroiditis.
Immunogenetics. |
| Y. Yan, J. Panos, D.
J. McCormick, Q. Wan, A. A. Giraldo, V. Brusic, C. S. David and Y. M. Kong:
Characterization of a navel H2A -E+ transgenic model susceptible to heterologous
but not self thyroglobulin in autoimmune thyroiditis: Thyroiditis transfer
with Vß8+ T cells. Cellular Immunology, 212, 63-70, 2001. |
| Q. Wan, M. Kita, J.C.
Flynn, J.C. Panos, R.W. Motte, T. F. Davies, A.A. Giraldo, C.S. David and
Y.M. Kong: Participation of Vß 13 and Vß 1 T cells in transfer
thyroiditis after activation of mouse thyroglobulin-primed T cells by Superantigen
staphylococcal enterotoxin A. Cellular Immunology, 213, 149-157, 2001. |
| Q. Wan, R. Shah, J.C.
Panos, A. A. Giraldo, C. S. David and Y. M. Kong, HLA-DR and HLA-DQ polymorphism
in human thyroglobulin-induced autoimmune thyroiditis: DR3 and DQ8 transgenic
mice are susceptible. Human Immunology, 63, 301-310, 2002. |
| J. C. Flynn, Q. Wan,
J. Panos, D. J. McCormick, A. A. Giraldo, C. S. David and Y. M. Kong, Coexpression
of susceptible and resistant HLA class II transgenes in murine experimental
autoimmune thyroiditis: DQ8 molecules down regulate DR3-mediated thyroiditis.
J Autoimmunity, 18(3): 213-20. 2002. |
| Y. M. Kong, J. C. Flynn,
Q. Wan, and C. S. David: HLA and H2 Class II transgenic mouse models to
study susceptibility and protection in autoimmune thyroiditis: J. Autoimmunity,
36 (6-7): 397-404. 2003. |
| J.C. Flynn, A. Gardas,
Q. Wan, M. Gora, G. Alsharabi, W.Z. Wei, A. A. Giraldo, C.S. David, Y.M.
Kong and J.P. Banga: Superiority of thyroid peroxidase DNA over protein
immunization in replicating human thyroid autoimmunity in HLA-DRB1*0301
(DR3) transgenic mice. Clinical and Experimental Immunology, 137 (3): 503-512
Sep 2004. |
| J.C. Flynn, D.J. McCormick,
V. Brusic, Q. Wan, J. Panos,A.A. Giraldo, C. S. David and Y.M. Kong: Pathogenic
human thyroglobulin peptides in HLA-DR3 transgenic mouse model of autoimmune
thyroiditis". Cellular Immunology, 229(2): 79-85. June 2004. |
| R. J. Robbins,
Q. Wan, R. K. Grewal, R. Reibke, M. Gonen, H. W. Strauss, R. M. Tuttle,
W. Drucker, S.M. Larson: Real-time Prognosis for Metastatic Thyroid Carcinoma
Based on FDG-PET Scanning. J Clin Endocrinol Metab. 2005-epub ahead of print.
Nov 22, 2005. |
